HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kefeng Ding Selected Research
Kefeng Ding Research Topics
Disease
38
Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 01/2012
37
Neoplasms (Cancer)
04/2024 - 01/2014
16
Neoplasm Metastasis (Metastasis)
01/2024 - 01/2017
8
Colonic Neoplasms (Colon Cancer)
04/2024 - 05/2018
4
Microsatellite Instability
01/2024 - 01/2023
4
Adenocarcinoma
08/2023 - 01/2015
4
Carcinogenesis
01/2023 - 12/2015
3
Anastomotic Leak
01/2024 - 01/2023
3
Breast Neoplasms (Breast Cancer)
11/2021 - 10/2016
2
Pathologic Complete Response
04/2024 - 01/2019
2
Chronic Obstructive Pulmonary Disease (COPD)
01/2024 - 01/2023
2
Inflammation (Inflammations)
05/2023 - 11/2022
2
Hepatocellular Carcinoma (Hepatoma)
11/2022 - 01/2020
2
Stomach Neoplasms (Stomach Cancer)
06/2022 - 04/2017
2
Rectal Neoplasms (Rectal Cancer)
01/2019 - 01/2019
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2017 - 01/2017
1
Lymphatic Metastasis
04/2024
1
Genetic Risk Score
11/2023
1
Neutropenia
08/2023
1
Genetic Predisposition to Disease (Genetic Predisposition)
05/2023
1
Disease Progression
01/2023
1
Autoimmune Diseases (Autoimmune Disease)
01/2023
1
COVID-19
06/2022
1
Hypoxia (Hypoxemia)
01/2021
1
Urinary Bladder Neoplasms (Bladder Cancer)
01/2021
1
Adenoma (Adenomas)
01/2021
1
Colitis
01/2021
Drug/Important Bio-Agent (IBA)
9
Proteins (Proteins, Gene)
FDA Link
11/2023 - 01/2014
7
RNA (Ribonucleic Acid)
IBA
12/2023 - 01/2020
6
Capecitabine (Xeloda)
FDA Link
04/2024 - 12/2020
6
Oxaliplatin (Eloxatin)
FDA Link
Generic
04/2024 - 01/2020
6
Biomarkers (Surrogate Marker)
IBA
08/2023 - 01/2020
3
Leucovorin (Folinic Acid)
FDA Link
04/2024 - 01/2020
3
Monoclonal Antibodies
IBA
11/2023 - 01/2023
3
Bevacizumab (Avastin)
FDA Link
08/2023 - 01/2023
3
Angiopoietin-Like Protein 1
IBA
01/2022 - 12/2017
3
MicroRNAs (MicroRNA)
IBA
01/2021 - 01/2017
3
Long Noncoding RNA
IBA
01/2020 - 01/2017
2
Fluorouracil (Carac)
FDA Link
Generic
04/2024 - 12/2020
2
Immune Checkpoint Inhibitors
IBA
03/2024 - 07/2023
2
ON 01910
IBA
11/2023 - 08/2021
2
Sulfones
IBA
11/2023 - 08/2021
2
sintilimab
IBA
08/2023 - 07/2023
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
07/2023 - 01/2023
2
anlotinib
IBA
01/2023 - 01/2022
2
Pancreatic Ribonuclease (Ribonuclease A)
IBA
03/2022 - 01/2019
2
angiogenin
IBA
03/2022 - 01/2019
2
Indicators and Reagents (Reagents)
IBA
10/2021 - 01/2020
2
Carcinoembryonic Antigen
IBA
06/2021 - 01/2017
2
Hepatocyte Nuclear Factor 6
IBA
01/2019 - 01/2012
1
A 7 (A-7)
IBA
04/2024
1
Neoplasm Antigens (Tumor Antigens)
IBA
03/2024
1
Interferon-gamma (Interferon, gamma)
IBA
03/2024
1
c-Mer Tyrosine Kinase
IBA
12/2023
1
Anti-Bacterial Agents (Antibiotics)
IBA
11/2023
1
ORALIT (ORS)
IBA
11/2023
1
Galactoside 2-alpha-L-fucosyltransferase (Fucosyltransferase 2)
IBA
11/2023
1
Cytochrome P-450 CYP1A1 (CYP1A1)
IBA
10/2023
1
Ephrin-A1 (Ephrin A1)
IBA
10/2023
1
Alanine Transaminase (SGPT)
IBA
08/2023
1
Endothelial Growth Factors
IBA
01/2023
1
N-methyladenosine
IBA
01/2023
1
ErbB Receptors (EGF Receptor)
IBA
01/2023
1
Proteome
IBA
01/2023
1
Polytetrafluoroethylene (Teflon)
FDA Link
11/2022
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
11/2022
1
Cell-Free Nucleic Acids
IBA
11/2022
1
Explosive Agents (Explosives)
IBA
06/2022
1
Angiogenic Proteins
IBA
03/2022
1
Tyrosine Kinase Inhibitors
IBA
01/2022
1
Methyltransferases
IBA
01/2022
1
Zinc Oxide
FDA Link
11/2021
1
Silicon Dioxide (Silica)
FDA Link
Generic
11/2021
1
Hydrogen Sulfide (Sulfide, Hydrogen)
IBA
11/2021
1
Enzymes
IBA
11/2021
1
Therapeutic Uses
IBA
11/2021
1
Protein Isoforms (Isoforms)
IBA
08/2021
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
08/2021
1
Antigens
IBA
06/2021
1
Carbohydrates
IBA
06/2021
1
Albumins
IBA
06/2021
1
Cisplatin (Platino)
FDA Link
Generic
01/2021
1
Dextrans (Dextran)
FDA Link
01/2021
1
Disulfiram (Antabuse)
FDA Link
01/2021
1
Bacterial DNA
IBA
01/2021
Therapy/Procedure
13
Therapeutics
12/2023 - 03/2016
7
Drug Therapy (Chemotherapy)
07/2023 - 01/2019
6
Neoadjuvant Therapy
04/2024 - 01/2019
6
Immunotherapy
01/2024 - 01/2018
3
Lymph Node Excision (Lymph Node Dissection)
11/2023 - 01/2019
3
Adjuvant Chemotherapy
01/2022 - 05/2016
2
Cytoreduction Surgical Procedures
01/2024 - 10/2016
2
Colectomy
11/2023 - 01/2021
2
Aftercare (After-Treatment)
08/2023 - 06/2022
1
Hyperthermic Intraperitoneal Chemotherapy
01/2024
1
Ileostomy
01/2023
1
Transplantation
11/2022
1
Intra-Arterial Infusions
06/2022
1
Precision Medicine
11/2021
1
Nanospheres
11/2021